HealthTab™ to Expand Across North East London
HealthTab™ to Power NHS Pilot
Avricore Health’s HealthTab™ Platform Expands to North Central London in Groundbreaking NHS Pharmacy-Led Cardiovascular Project
Avricore Grants Options
Avricore Appoints Rodger Seccombe as CEO
AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
Avricore Health Full Year 2024 Earnings: CA$0.007 loss per share (vs CA$0.007 loss in FY 2023)
AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track
Avricore Health Inc. (CVE:AVCR) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK
3 TSX Penny Stocks With Market Caps Below CA$20M
Discover 3 TSX Penny Stocks To Watch In December 2024
Avricore Health Corporate Update: Effective Plan, Resources Result in Success
Avricore Health Refocuses Strategy to Unlock Growth Potential
Avricore Health And 2 Other TSX Penny Stocks To Watch
Avricore Health Recognized in Deloitte’s 2024 Technology Fast 50™ Companies to Watch
Keynotes and 50 Companies to Present at the Planet MicroCap Showcase: VANCOUVER in association with Small Cap Discoveries on September 25-26, 2024 at the Fairmont Waterfront Vancouver
Avricore Health Second Quarter 2024 Earnings: EPS: CA$0.001 (vs CA$0.003 loss in 2Q 2023)
Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.